Skip to main content

Actors and Networks database

The evolving field of gene and cell therapy is supported by a large community of academic, clinical, translational, regulatory and patient organisations. The Actors and Networks database maps these stakeholders in Europe and beyond, their activities, and resources they have produced. 

EuroGCT has developed and compiled this database for those interested in identifying the actors involved at each stage of the pathways bringing gene and cell therapies from lab to clinic. Coming from an academic perspective, our focus is to map information that has not been mapped elsewhere. This includes documenting the various types of interconnected regulators, patient groups actively involved along the pathways, and non-profit organisations devoted to therapy development. In its first iteration, this database does not yet include commercial partners and service providers.

Additional complementary work by other organisations on GCT stakeholders mapping can be found here.

A scientific paper on actors has also been published in Humanities and Social Sciences Communications. You can find its lay summary here.

Showing 10 of 373

Germany Institute for Quality and Efficiency in Health Care (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen) (IQWIG)

Region/Country:  
  • Countries in the EU/EEA
  • Germany

Type of Actor:

  • Regulators
  • HTA Bodies

Development Stage:

  • Commercialisation

GMED SAS

Region/Country:  
  • Countries in the EU/EEA
  • France

Type of Actor:

  • Regulators
  • Medical Devices Entities
  • Notified Bodies

Development Stage:

  • Manufacturing
  • Commercialisation

Greek Coordinating Haemovigilance Centre (Συντονιστικό Κέντρο Αιμοεπαγρύπνησης και Επιτήρησης Μεταγγίσεων) (SKAEM / ΣΚΑΕΜ)

Region/Country:  
  • Countries in the EU/EEA
  • Greece

Type of Actor:

  • Regulators
  • Other National competent authorities
  • Competent Authorities for Blood and Blood Components

Development Stage:

  • Manufacturing
  • Commercialisation

Greek Ministry of Health (Υπουργείου Υγείας) (MOH)

Region/Country:  
  • Countries in the EU/EEA
  • Greece

Type of Actor:

  • Regulators
  • Other National competent authorities
  • Competent Authorities for Tissues and Cells
  • Competent Authorities for Blood and Blood Components

Development Stage:

  • Fundamental Research
  • Translational Research
  • Clinical Research
  • Manufacturing
  • Commercialisation

Greek Ministry of Health – National Health Technology Assessment and Reimbursement Committee (Υπουργείου Υγείας - Επιτροπής Αξιολόγησης και Αποζημίωσης Φαρμάκων Ανθρώπινης Χρήσης)

Type of Actor:

  • Regulators
  • HTA Bodies

Development Stage:

  • Commercialisation

Greek Ministry of the Environment and Energy (Υπουργείο Περιβάλλοντος και Ενέργειας)

Region/Country:  
  • Countries in the EU/EEA
  • Greece

Type of Actor:

  • Regulators
  • Other National competent authorities
  • Competent Authorities for GMO

Development Stage:

  • Fundamental Research
  • Clinical Research
  • Manufacturing
  • Commercialisation

Greek National Blood Donation Centre (Εθνικό Κέντρο Αιμοδοσίας) (ΕΚΕΑ)

Region/Country:  
  • Countries in the EU/EEA
  • Greece

Type of Actor:

  • Regulators
  • Other National competent authorities
  • Competent Authorities for Blood and Blood Components

Development Stage:

  • Manufacturing
  • Commercialisation

Greek National Organization for Medicines (Εθνικός Οργανισμός Φαρμάκων) (EOF / ΕΟΦ)

Region/Country:  
  • Countries in the EU/EEA
  • Greece
Website:  

Type of Actor:

  • Regulators
  • Medicines Agencies
  • National Medicines Agencies
  • Medical Devices Entities
  • Medical Device Authorities
  • National Medical Device Authorities
  • Other National competent authorities
  • Competent Authorities for GMO

Development Stage:

  • Fundamental Research
  • Clinical Research
  • Manufacturing
  • Commercialisation

Heads of Medicines Agencies (HMA)

Region/Country:  
  • EU/EEA

Type of Actor:

  • Regulators
  • Medicines Agencies
  • Supranational Medicines Agencies

Development Stage:

  • Fundamental Research
  • Clinical Research
  • Manufacturing
  • Commercialisation

Health and Safety Executive for Northern Ireland (HSENI)

Region/Country:  
  • UK

Type of Actor:

  • Regulators
  • Other National competent authorities
  • Competent Authorities for GMO

Development Stage:

  • Fundamental Research
  • Clinical Research
  • Manufacturing
  • Commercialisation
Did you find the content on this page useful? If not, you can leave us a message so we can improve Send us your thoughts